Vemedia

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Vemedia - overview

Established

1961

Location

London, -, UK

Primary Industry

Consumer Products

About

Established in 1961 and headquartered in London, UK, Vemedia engages in the manufacture and sale of over the counter healthcare products and pharmaceutical ingredients. The company opearates a variety of brands including Excilor, a fungal nail treatment, Valdispert, central nervous system product, and Oenobiol, a beauty nutrition product.


Current Investors

Charterhouse Capital Partners, Cooperation Pharmaceutique Francaise

Primary Industry

Consumer Products

Sub Industries

Consumer Products, Pharmaceuticals

Website

www.vemedia.com

Verticals

Manufacturing

Company Stage

Add-on

Total Amount Raised

Subscriber access only

Vemedia - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Add-on, Trade SaleCompletedVemedia-
Add-onCompletedStardea-
Add-onCompletedOenobiol-
Add-onCompletedLabima SA-
Public to Private, Secondary BuyoutCompletedVemedia-

Displaying 1 - 5 of 7

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.